OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

OGI.TO Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

OrganiGram Holdings Inc.TSX: OGI.TO

Net Debt · Q2 FY2026 · quarter ended Mar 2026

Net debt remains negative

Q2 FY2026 net debt was -CA$45.75M, compared with -CA$3.64M a year earlier.

Context

  • Net debt amounted to 8.8% of total assets at the end of Q2 FY2026, up 8.1 pp from a year earlier.
  • Net debt grew in size in 1 of the last 3 fiscal years.

What to watch

Whether net debt keeps falling in the next quarterly balance sheet after a -1155.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$45.75M-5322.0% QoQ
Last fiscal yearSep 2025
-CA$74.84M+26.8% YoY
Year agoMar 2025
-CA$3.64M-1155.4% since
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1155.4%——
1 year+26.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Debt history

CAD · from the balance sheet

Latest · FY2025
(74.84M) CAD
Year-over-year change
+26.8%

Net Debt vs competitors

How OGI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so net debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -1155.4% is the lowest of 10, against a peer median of -132.3%.
  • Net debt amounts to 8.8% of total assets for OGI.TO, versus a peer median of 14.7%.
OGI.TO Competitors
Net Debt for OGI.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TSND.TOTerrAscend Corp.Mar 2026$214.88M USD-0.8%-9.8%39.1%
HLS.TOHLS Therapeutics Inc.Mar 2026$31.63M USD-31.3%-20.8%24.1%
XLY.TOAuxly Cannabis Group Inc.Mar 2026CA$12.87M CAD-73.3%-48.0%4.6%
CPH.TOCipher Pharmaceuticals Inc.Mar 2026-$5.99M USD-132.3%—3.9%
DR.TOMedical Facilities CorporationMar 2026-$29.12M USD-641.1%-47.8%10.5%
FRX.TOFennec Pharmaceuticals Inc.Mar 2026-$40.08M USD-1105.6%—55.9%
OGI.TOOrganiGram Holdings Inc.Mar 2026-CA$45.75M CAD-1155.4%—8.8%
EPRX.TOEupraxia Pharmaceuticals Inc.Mar 2026-$56.53M USD-106.3%—38.9%
WEED.TOCanopy Growth CorporationMar 2026-CA$85.97M CAD-136.6%—7.7%
ACB.TOAurora Cannabis Inc.Mar 2026-CA$88.62M CAD-165.8%—14.7%
Peer median (excluding OGI.TO) —-132.3%-34.3%14.7%

Competitors are the stored peer set for OGI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents55.37M68.52M33.86M106.75M83.59M
Short-term Investments128.48M30.4M0821K826K
Net Receivables21.29M46.37M30.16M37.15M64.86M
Inventory48.82M68.28M80.95M82.52M123.95M
Other Current Assets1.08M2.51M2.7M25.86M55.39M
Total Current Assets260.62M221.62M155.98M262.22M284.9M
Property, Plant & Equipment (Net)235.94M259.82M99.05M96.23M122.98M
Goodwill14.32M41.98M0052.52M
Intangible Assets2.73M14.26M10.62M8.09M48.51M
Long-term Investments6.11M7.07M13.72M40.73M49.55M
Tax Assets3.2M0000
Other Non-current Assets31.11M32.36M19.09M591K3.75M
Total Non-current Assets293.4M355.48M142.48M145.64M277.31M
Total Assets554.02M577.11M298.46M407.86M562.21M
Account Payables18.95M40.86M20.01M47.1M89.25M
Short-term Debt80K80K76K60K25K
Tax Payables01.42M94K00
Deferred Revenue02.44M94K00
Other Current Liabilities2.75M10.98M1.24M5.14M35.91M
Total Current Liabilities26.27M55.29M22.43M53.32M126.16M
Long-term Debt230K155K79K25K0
Deferred Tax Liabilities03.62M000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities43.07M7.79M771K45.18M79.17M
Total Non-current Liabilities47.95M13.76M4.4M48.55M86.92M
Total Liabilities74.21M69.05M26.83M101.87M213.08M
Common Stock730.8M769.73M776.91M852.89M919.91M
Retained Earnings(275.64M)(289.93M)(538.53M)(583.97M)(608.73M)
Accumulated OCI24.65M28.26M33.25M37.07M37.95M
Other Stockholders Equity00000
Minority Interest00000
Total Equity479.81M508.06M271.62M305.99M349.13M
Total Debt4.96M3.36M4.72M4.46M8.75M
Net Debt(50.4M)(65.16M)(29.15M)(102.29M)(74.84M)

OrganiGram Holdings Inc.

TSX:OGI.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.